• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

Dol­lars flow with three new pub­lic of­fer­ings, two pri­vate place­ments

3 years ago
Financing

Il­lu­mi­na names Ho­log­ic CEO as new board mem­ber and chair

3 years ago
People
Pharma

Take­da ax­es gene ther­a­py deal with Po­sei­da Ther­a­peu­tics amid broad­er re­think

3 years ago
Deals
Cell/Gene Tx

No­var­tis’ Kisqali pre­vents breast can­cer from com­ing back for longer — but can it best Eli Lil­ly’s Verzenio? ...

3 years ago
R&D

Catal­ent makes ad­di­tion­al lay­offs at In­di­ana fa­cil­i­ty

3 years ago
People
Manufacturing

Ger­man ra­dio­phar­ma biotech ac­quires British start­up in tiny deal

3 years ago
Deals

On­corus lays off most of its re­main­ing team, warns of wind-down as it takes one last shot at deal­mak­ing

3 years ago
People

Ex­clu­sive: Affi­ni-T taps Sanofi alum to lead hunt for part­ner­ships; Alk­er­mes locks in CEO for on­col­o­gy spin­out

3 years ago
Peer Review

Eu­ro­pean Par­lia­ment calls mem­ber states to ac­tion on an­timi­cro­bial re­sis­tance

3 years ago
Pharma

Ky­owa Kirin re­news sup­port for foun­da­tion that ful­fills wish­es for ter­mi­nal­ly ill adults

3 years ago
Pharma
Marketing

San­doz plans to stay lo­cal af­ter No­var­tis sep­a­ra­tion, se­lect­ing new HQ in Basel

3 years ago
People
Pharma

Am­gen cen­ters can­cer pa­tients’ voic­es in new YouTube se­ries

3 years ago
Pharma
Marketing

Vi­a­tris tar­gets ul­cer­a­tive col­i­tis in Japan with $10M agree­ment with Swedish phar­ma In­Dex

3 years ago
Pharma

CMS makes it of­fi­cial: Cov­er­age for new Alzheimer's drugs once full ap­provals ar­rive

3 years ago
Pharma

Man­u­fac­tur­ing roundup: Astel­las to sell Dutch fa­cil­i­ty to Del­pharm; Au­ri­gene in­vest­ing $40M in­to In­dia man­u­fac­tur­ing ...

3 years ago
Manufacturing

Green­Light Bio­sciences se­cures merg­er as it looks to go pri­vate

3 years ago
R&D
Manufacturing

Bausch + Lomb to pro­mote three SVPs to ex­ec­u­tive team

3 years ago
People

Bay­er buys li­cense to Cedil­la pre­clin­i­cal can­cer pro­gram; MEI Phar­ma says no to un­so­licit­ed of­fer

3 years ago
News Briefing

Roche plans to di­vest from lega­cy Genen­tech man­u­fac­tur­ing fa­cil­i­ty in Cal­i­for­nia

3 years ago
Manufacturing

FDA lifts hold on Mol­e­c­u­lar Tem­plates’ mul­ti­ple myelo­ma tri­al af­ter less than two months

3 years ago
R&D
FDA+

Mark Cuban read­ies to fight Hu­mi­ra's megablock­buster fran­chise next month

3 years ago
Pharma

Roger Perl­mut­ter builds Eikon's pipeline with deal-mak­ing flur­ry, rais­ing $106M more

3 years ago
Financing
Deals

Far­al­lon says it's won all de­sired board seats from Ex­elix­is af­ter share­hold­er vote

3 years ago
People

Lon­za shells out $107M cash to snap up Synaf­fix and its ADC plat­form

3 years ago
Deals
Manufacturing
First page Previous page 333334335336337338339 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times